NEOPLASMS BY SITE

This early-phase study tested a new type of cell therapy called RD13-02 in a very small group of patients with aggressive blood cancers that had returned or not responded to standard treatments. The main goals were to check if the treatment was safe and to see how the modified im…

This early-stage study tested a new way to give the cancer immunotherapy drug nivolumab—as an injection under the skin instead of into a vein. It involved 139 people with various advanced cancers, including lung, kidney, and skin cancers. The main goal was to see how the body pro…

This study tested the safety and effectiveness of a new immunotherapy drug called BMS-986016 (relatlimab), given alone and in combination with the established drug nivolumab. It involved over 1,400 people with advanced solid tumors that had spread or could not be removed by surge…

This study tested if two new, advanced imaging scans could find prostate cancers that a standard MRI scan might miss in patients planning for a targeted therapy or surgery. The goal was to create a more accurate 'map' of the cancer to help guide treatment decisions. Researchers c…